Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebocontrolled trial evaluating its effects 5-6 years after completion of the primary series (vol 16, pg 523, 2019)
- 浏览0
Human vaccines & immunotherapeutics.
2819-2819页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



